Results 141 to 150 of about 199,281 (229)

Development and Application of Organic Sonosensitizers in Cancer Therapy

open access: yesAggregate, EarlyView.
This review provides a comprehensive overview of organic sonosensitizers employed in cancer treatment, describing their underlying mechanisms and structure‐activity relationship in terms of sonodynamic therapy. The significance of nanotechnology and combination therapy with other oncological modalities (photothermal therapy, photodynamic therapy, etc.)
Yuhan Ding   +5 more
wiley   +1 more source

Ibuprofen in a Lipid Bilayer: Nanoscale Spatial Arrangement. [PDF]

open access: yesMembranes (Basel), 2022
Kashnik AS, Baranov DS, Dzuba SA.
europepmc   +1 more source

Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery

open access: yesAggregate, EarlyView.
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail   +5 more
wiley   +1 more source

Pegylated gold nanoparticles interact with lipid bilayer and human serum albumin and transferrin. [PDF]

open access: yesSci Rep
Okła E   +10 more
europepmc   +1 more source

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils

open access: yesAggregate, EarlyView.
This review addresses the gap between strong evidence for the involvement of amyloid fibrils in neurodegeneration and the failure of anti‐amyloid therapies, a phenomenon herein termed the “amyloid paradox.” To address this paradox, we provide a comprehensive summary of the current understanding of fibrils' pathogenic properties and mechanisms ...
Maksim I. Sulatsky   +3 more
wiley   +1 more source

Aqueous Ionic Liquid Mixtures as Minimal Models of Lipid Bilayer Membranes. [PDF]

open access: yesACS Biomater Sci Eng
Volmer J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy